Immunotherapy “Shock” a case series of PD-L1 100% and pembrolizumab first-line treatment

In this decade a “bloom” of novel therapies has been observed for non-small cell lung cancer. We have new tools for the diagnosis of lung cancer and also we can re-biospy easier than before in different lesions and obtain tissue samples in order to investigate whether a patient can receive new targe...

Descripción completa

Detalles Bibliográficos
Autores principales: Zarogoulidis, Paul, Athanasiou, Evaggelia, Tsiouda, Theodora, Hatzibougias, Dimitrios, Huang, Haidong, Bai, Chong, Trakada, Georgia, Veletza, Lemonia, Kallianos, Anastasios, Kosmidis, Christoforos, Barbetakis, Nikolaos, Paliouras, Dimitrios, Rapti, Aggeliki, Drougas, Dimitrios, Hohenforst-Schmidt, Wolfgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5576975/
https://www.ncbi.nlm.nih.gov/pubmed/28879076
http://dx.doi.org/10.1016/j.rmcr.2017.08.017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5576975/
https://www.ncbi.nlm.nih.gov/pubmed/28879076
http://dx.doi.org/10.1016/j.rmcr.2017.08.017

Ejemplares similares